WWW.DISSERS.RU


...
    !

Pages:     | 1 | 2 ||

13. jorntorp, P. Endocrine abnormality in obesity/ . 38. Novakovich, B. Occurrence of th metabolic syndrome jorntorp// Diabetes rev. 1997. V1. 5. . 52-68. in the ultion of the town of Novi Sad/ . Novakovich, .

14. Califf, R.M. Insulin resistance: a global epidemic in need vic// Med. Pregl.2001. Vol.54. . 17-20.

of effective therapie/ R.M. Califf// Eur. Heart J. 2003. Vol. 5. 39. Obesity as an independent risk factor for cardiovascular . 13-18. disease: a 26-year follow-up of participants in the Framinghman 15. Clinical Managemet of Metabolic Syndrome. Report of heart study/ H.B. Hubert, M. Feinleib, P.M. Mc Namara et al.// the American Heart association. National Heart. Lung and Blood Circulation. 1983. Vol.67. . 968-977.

Institute/ American Diabetes Association Conference on Scientific 40. Polymorphiu of the b3 adrenergetic receptor gene affects Issues Related to Management/ S.M. Grundy, B. Hansen, S.C. basal metabolic rate in obese Finns/ R. Sipilainen, . Uusitupa, Smith et al.// Circulation. 2004. Vol. 109. . 551-556. S. Heikkinsen et al.// Diabetes. 1997. Vl. 46. . 77-80.

16. Danforth, E. Failure of adipocyte differentiation causes 41. Reaven, G.M. Banting lecture. 1988. Role of insulin type II diabetes mellitus/ . Danforth// Nature Genet. 2000. resistance in human disease/ G.M. Reaven// Diabetes. 1988.

Vol.26. . 13-15. Vol.37. . 1595-1607.

17. Darvin, D. Metabolic syndrome: Time for action/ D. 42. Rgenau, . gnosis aspects of the metalic Darvin// Amer. Fam. Phys. 2002. Vol.10. . 6-12. syndrome/ . Rgenau // J. Insur. Med. 1998. Vol.30. 18. Epidemiological study on obesity and its comorbidities in .180-189.

urban Chinese older then 20 years of age in Shanghai, China/ 43. Relationship plasma leptin to plasma insulin and W.P. Jia, K.S. Xiang, L. Chen et al.// Obes. Rev. 2002. adiposity in normal weight and overweight women: effect of 3. . 157165. dietary fat content and sustained weight loss/ . Havel, S. Kasin19. Ferranini, E., The association of hypertension, diabetes Karakas, W. Mueller et al.// J. clin. Endocrin. 1996. Vl. 81.

and obesity/ . Ferranini, R.A. De Fronzo// J. Nephrol. 1989. . 4406-4413.

V1. 1. . 3 15. 44. Resistance of multiple cardiovascular risk clustering 20. Ford, A. Metabolic syndrome/. Ford // related to syndrome X from childhood to young adulthood. The . 2002. . 5056. Bogalusa Heart Study/ W.H. , S.R. Srinivastan, W.A.

21. Ford, A. A comparison of the prevalence of the metabolic Wattingney et al.// Arch. Intern. Med. 1994. Vl. 54. .

syndrome using two proposed definitions/ . Ford// Diabetes 1842-1847.

Care. 2003. Vol.26. . 575-581. 45. Ruderman, N. Cell biology: chewing the fat ACC and 22. Ford, E.S. Prevalence of the metabolic syndrome among energy balance/ N. Ruderman, J.S. Flier// Science. 2001. US adults: findings from the third National Health and Nutrition Vol.291. . 2558-2559.

Examination Survey/ E.S. Ford, W.H. Qiles, W. Dietz// JAMA. 46. SREBP 1, a basic helix loop leucine. Zipper protein 2002. Vol.287. . 356-359. that control transcription of the low density lipoprotein receptor 23. Genetic combination of polymorphism of the GLUT 1 and genes/ . Yocoyama, . Wang, . Brigges et al.// Cell. 1993.

GLUT 4 genes to the susceptibility to type II (non-insulin dependent) V1. 75. . 187-197.

diabetes mellitus in different populations/ . Pontiroli, F. Capra, F. 47. Sundstrom, J. Recognition of metabolic syndrome is an Veglia et al.// Acta diabetol. 1996. V1. 3. . 193-197. additional of a long. term death risk in middle-aged men/ J.

24. Haffner, S. Relationship of proinsulin and insulin to Sundstrom// Br. M.J. 2006.

cardiovascular risk factors in nondiabetic subjects/ S. Haffner, L. 48. The role of neuropeptide Y in the antiobesity action of the Mykkanen, M. Stern// Diabetologia. 1993. Vol.42. . obese gene product / . Stephens, . Basinski, . Bristow et al.// 1297-1302. Nature. 1995.V1..530532.

25. Halffner, S.M. Insulin and blood pressure in the San 49. Tsao, T. Muscle specific transgenic complementation Antonio Heart Study. A review/ S.M. Halffner// Cardiovasc. Risk of GLUT 4 deficient mice. Effects on glucose but not lipid factors. 1993. V1. 1. . 18-27. metabolism/ . Tsao, . Stenbit// J. Clin. Invest. 1997. 26. Henefeld, M. Das metabolishe syndrome/ . Henefeld, W. V1. 100. . 671 677.

Leonhardt// Deutsch. Qes. Wes. 1980. Vol.36. . 545-551. 50. Tumor necrosis factor alpha in serum of obese patients:

27. High plasma immunoreactive leptin level in essential fall with weight loss/ . Dandona, R. Weinstock, K. Thusn, et al.

hypertension/ J. gata, . Masuda, . Tacada et al.//Am. J. // J. clin. Endocr. 1998. Vl. 83. . 29072910.

Hypertens. 1997. V1.10. .1171-1174.

- 3 (21) 2008, -

Pages:     | 1 | 2 ||



2011 www.dissers.ru -

, .
, , , , 1-2 .